Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double‐blind, placebo‐controlled feasibility trial

Abstract Thrombocytopenic patients have an increased risk of bleeding when undergoing invasive procedures. In a multicentre, phase II, blinded, randomised, controlled feasibility trial, critically ill patients with platelet count 100 × 109/L or less were randomised 1:1 to intravenous desmopressin (0...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Michael J. R. Desborough, Emma Laing, Daphne Kounali, Ana Mora, Renate Hodge, Siobhan Martin, Helen Thomas, Cara Hudson, Joseph Parsons, Akshay Shah, Paula Hutton, Tim Parke, Matthew P. Wise, Matthew Morgan, Stuart McKechnie, Simon J. Stanworth
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2024-08-01
Schriftenreihe:	eJHaem
Schlagworte:	bleeding disorders desmopressin thrombocytopenia
Online-Zugang:	https://doi.org/10.1002/jha2.955
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!